CALT — Calliditas Therapeutics AB Share News
0.000.00%
Last trade - 00:00- $1.10bn
- $1.12bn
- SEK1.21bn
Brief: Calliditas Therapeutics Establishes A U.S. At-The-Market Program
Brief: Calliditas Therapeutics AB Files For Mixed Shelf Of Up To $200 Million
Brief: Calliditas Therapeutics AB Announces Issuance And Repurchase Of C-Shares
Brief: Calliditas Therapeutics Receives Positive CHMP Opinion In IgA Nephropathy
Brief: Calliditas Q1 Operating Loss At SEK 208.4 Million
Brief: Calliditas Therapeutics: Regulatory Update On EMA Process For Nefecon
Brief: Calliditas Therapeutics: Updated Regulatory Plans For NEFECON In China
Brief: Calliditas Therapeutics Expands Licensing Agreement With Everest Medicine To South Korea
Brief: Everest Medicines Enters Into Agreement With Calliditas Therapeutics To Develop And Commercialize NEFECON
U.S. RESEARCH ROUNDUP-Biodelivery Sciences International, Foot Locker, Universal Health Services
Brief: Calliditas Therapeutics Q4 Operating Loss At SEK 222.1 Million
U.S. STOCKS ON THE MOVE-Adobe, Accenture, Under Armour, Novavax
U.S. STOCKS ON THE MOVE-Tesla, Delta Air Lines, Accenture, Calliditas Therapeutics
U.S. STOCKS ON THE MOVE-Accenture, Lennar, Novavax, Calliditas Therapeutics
U.S. RESEARCH ROUNDUP-Cerence, Hirequest, Magna International
Brief: FDA Grants Calliditas Therapeutics Accelerated Approval Of TARPEYO
NASDAQ RESUMED AT 04:31 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:07 PM
Brief: Calliditas Q3 Net Sales At SEK 198.2 Million